Press Releases
14 January 2020
REDWOOD CITY, Calif., Jan. 14, 2020 /PRNewswire/ -- Synthego, the genome engineering company, today announced it has adopted Good Manufacturing Practice (GMP) standards to provide academic and indus
Read more...14 January 2020
PRINCETON, N.J., Jan. 14, 2020 /PRNewswire/ -- Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases where there is an unmet medical need, today issued an update letter from its President and Chief Executive Officer, Dr. Chris
Read more...14 January 2020
NEW YORK, Jan. 14, 2020 /PRNewswire/ -- Adverse outcomes from childhood exposures to lead and mercury are on the decline in the United States, likely due to decades of restrictions on the use of heavy metals, a new study finds.
Read more...NEW YORK, Jan. 14, 2020 /PRNewswire/ -- Today, KIND Healthy Snacks (KIND) announces it adopted nutrition research led by the United States Department of Agriculture (USDA)'s Agri
Read more...14 January 2020
CAMBRIDGE, Mass., Jan. 14, 2020 /PRNewswire/ -- Swoop, the company driving better patient outcomes with its AI-generated digital audiences for the health industry, announced today it has become the newest member of the Network Advertising Initiative (NAI), the leading self-regulatory industry association dedicated to responsible data collection and its use for digit
Read more...14 January 2020
MADRID, Jan. 14, 2020 /PRNewswire/ -- Pharmactive Biotech Products S.L. introduces its new generation of aged black garlic extract for functional food applications and the culinary market, launched under the brand ABG10+®. The extract is obtained from fresh garlic (Allium Sativum L.) that has been aged, a process which alters the physiochemical properties of garlic r
Read more...14 January 2020
TEL AVIV, Israel, Jan. 14, 2020 /PRNewswire/ -- BioLineRx Ltd. (NASDAQ: BLRX) (TASE: BLRX), a clinical-stage biopharmaceutical company focused on oncology, today announced that the European Commission (EC) has granted Orphan Drug Designation to its lead oncology candidate, Motixafortide (BL-8040), for the treatment of pancreatic cancer, based on a positive opin
Read more...IRVINE, Calif. and NEW YORK, Jan. 14, 2020 /PRNewswire/ -- Genomic Testing Cooperative, LCA (GTC), a cooperative (Co-Op) company o
Read more...14 January 2020
CHICAGO, Jan. 14, 2020 /PRNewswire/ -- Easterseals, the nation's leading nonprofit service provider and advocate for the one in four people living with disability in America today, recently elected Juan Otero and Frank Filippo to its National Board of Directors.
Read more...14 January 2020
SUNRISE, Fla., Jan. 14, 2020 /PRNewswire/ -- January is National Birth Defects Prevention Month, a nationwide effort to raise awareness about birth defects, their caus
Read more...
